China In Shine Investment Ltd 13D/13G Filings for Sorrento Therapeutics, Inc. (SRNE)

China In Shine Investment Ltd 13D and 13G filings for Sorrento Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2021-02-01
4:32 pm
Sale
2020-12-31 13G Sorrento Therapeutics, Inc.
SRNE
China In Shine Investment Ltd 4,760,801
1.800%
-7,239,458decrease
(-60.33%)
Filing